nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—ABCC8—penis—urinary bladder cancer	0.0584	0.146	CbGeAlD
Diazoxide—GLUL—prostate gland—urinary bladder cancer	0.0161	0.0403	CbGeAlD
Diazoxide—KCNMA1—prostate gland—urinary bladder cancer	0.015	0.0374	CbGeAlD
Diazoxide—SLC12A3—renal system—urinary bladder cancer	0.0148	0.0368	CbGeAlD
Diazoxide—ABCC8—prostate gland—urinary bladder cancer	0.014	0.0348	CbGeAlD
Diazoxide—GLUL—epithelium—urinary bladder cancer	0.0119	0.0296	CbGeAlD
Diazoxide—SLC12A3—female reproductive system—urinary bladder cancer	0.0118	0.0295	CbGeAlD
Diazoxide—ABCC8—seminal vesicle—urinary bladder cancer	0.0118	0.0294	CbGeAlD
Diazoxide—GLUL—smooth muscle tissue—urinary bladder cancer	0.0114	0.0285	CbGeAlD
Diazoxide—KCNMA1—epithelium—urinary bladder cancer	0.011	0.0275	CbGeAlD
Diazoxide—GLUL—renal system—urinary bladder cancer	0.011	0.0274	CbGeAlD
Diazoxide—GLUL—urethra—urinary bladder cancer	0.0108	0.027	CbGeAlD
Diazoxide—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.0106	0.0265	CbGeAlD
Diazoxide—KCNMA1—renal system—urinary bladder cancer	0.0102	0.0255	CbGeAlD
Diazoxide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.00988	0.0247	CbGeAlD
Diazoxide—ATP1A1—prostate gland—urinary bladder cancer	0.00962	0.024	CbGeAlD
Diazoxide—ABCC8—renal system—urinary bladder cancer	0.00951	0.0237	CbGeAlD
Diazoxide—GLUL—female reproductive system—urinary bladder cancer	0.00881	0.022	CbGeAlD
Diazoxide—KCNJ11—female reproductive system—urinary bladder cancer	0.00827	0.0206	CbGeAlD
Diazoxide—KCNMA1—female reproductive system—urinary bladder cancer	0.00818	0.0204	CbGeAlD
Diazoxide—ATP1A1—seminal vesicle—urinary bladder cancer	0.00814	0.0203	CbGeAlD
Diazoxide—GLUL—vagina—urinary bladder cancer	0.00797	0.0199	CbGeAlD
Diazoxide—CA1—renal system—urinary bladder cancer	0.00775	0.0193	CbGeAlD
Diazoxide—CA2—prostate gland—urinary bladder cancer	0.00737	0.0184	CbGeAlD
Diazoxide—ATP1A1—epithelium—urinary bladder cancer	0.00707	0.0176	CbGeAlD
Diazoxide—ATP1A1—smooth muscle tissue—urinary bladder cancer	0.00681	0.017	CbGeAlD
Diazoxide—ATP1A1—renal system—urinary bladder cancer	0.00656	0.0164	CbGeAlD
Diazoxide—ATP1A1—urethra—urinary bladder cancer	0.00644	0.0161	CbGeAlD
Diazoxide—CA2—seminal vesicle—urinary bladder cancer	0.00624	0.0156	CbGeAlD
Diazoxide—CA1—female reproductive system—urinary bladder cancer	0.00621	0.0155	CbGeAlD
Diazoxide—CA2—epithelium—urinary bladder cancer	0.00542	0.0135	CbGeAlD
Diazoxide—ATP1A1—female reproductive system—urinary bladder cancer	0.00525	0.0131	CbGeAlD
Diazoxide—CA2—smooth muscle tissue—urinary bladder cancer	0.00522	0.013	CbGeAlD
Diazoxide—GLUL—lymph node—urinary bladder cancer	0.00515	0.0129	CbGeAlD
Diazoxide—CA2—renal system—urinary bladder cancer	0.00503	0.0125	CbGeAlD
Diazoxide—KCNJ11—lymph node—urinary bladder cancer	0.00484	0.0121	CbGeAlD
Diazoxide—KCNMA1—lymph node—urinary bladder cancer	0.00478	0.0119	CbGeAlD
Diazoxide—ATP1A1—vagina—urinary bladder cancer	0.00475	0.0119	CbGeAlD
Diazoxide—CA2—female reproductive system—urinary bladder cancer	0.00402	0.01	CbGeAlD
Diazoxide—CA2—vagina—urinary bladder cancer	0.00364	0.00908	CbGeAlD
Diazoxide—CA1—lymph node—urinary bladder cancer	0.00363	0.00906	CbGeAlD
Diazoxide—ATP1A1—Preimplantation Embryo—AQP3—urinary bladder cancer	0.00336	0.0558	CbGpPWpGaD
Diazoxide—ATP1A1—Preimplantation Embryo—CDX2—urinary bladder cancer	0.00322	0.0535	CbGpPWpGaD
Diazoxide—ATP1A1—lymph node—urinary bladder cancer	0.00307	0.00767	CbGeAlD
Diazoxide—CA1—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.00274	0.0455	CbGpPWpGaD
Diazoxide—GLUL—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.00252	0.0419	CbGpPWpGaD
Diazoxide—CA2—lymph node—urinary bladder cancer	0.00235	0.00587	CbGeAlD
Diazoxide—GLUL—TNF alpha Signaling Pathway—BIRC3—urinary bladder cancer	0.00214	0.0356	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00155	0.0258	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00151	0.0251	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.0015	0.00278	CcSEcCtD
Diazoxide—Vision blurred—Fluorouracil—urinary bladder cancer	0.0015	0.00278	CcSEcCtD
Diazoxide—Anorexia—Thiotepa—urinary bladder cancer	0.00149	0.00277	CcSEcCtD
Diazoxide—Flushing—Etoposide—urinary bladder cancer	0.00147	0.00273	CcSEcCtD
Diazoxide—Malaise—Gemcitabine—urinary bladder cancer	0.00146	0.0027	CcSEcCtD
Diazoxide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00145	0.00268	CcSEcCtD
Diazoxide—Vascular purpura—Epirubicin—urinary bladder cancer	0.00144	0.00266	CcSEcCtD
Diazoxide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00142	0.00264	CcSEcCtD
Diazoxide—Vision blurred—Cisplatin—urinary bladder cancer	0.00142	0.00263	CcSEcCtD
Diazoxide—Paraesthesia—Thiotepa—urinary bladder cancer	0.00141	0.00261	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.0014	0.0232	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.0014	0.00259	CcSEcCtD
Diazoxide—Hypertension—Gemcitabine—urinary bladder cancer	0.00139	0.00259	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.00139	0.00258	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.00138	0.023	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.00138	0.023	CbGpPWpGaD
Diazoxide—Chest pain—Gemcitabine—urinary bladder cancer	0.00138	0.00255	CcSEcCtD
Diazoxide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00136	0.00253	CcSEcCtD
Diazoxide—Discomfort—Gemcitabine—urinary bladder cancer	0.00136	0.00252	CcSEcCtD
Diazoxide—Malaise—Cisplatin—urinary bladder cancer	0.00136	0.00252	CcSEcCtD
Diazoxide—Chest pain—Fluorouracil—urinary bladder cancer	0.00135	0.00251	CcSEcCtD
Diazoxide—Leukopenia—Cisplatin—urinary bladder cancer	0.00135	0.0025	CcSEcCtD
Diazoxide—Pain—Thiotepa—urinary bladder cancer	0.00134	0.00249	CcSEcCtD
Diazoxide—Discomfort—Fluorouracil—urinary bladder cancer	0.00134	0.00248	CcSEcCtD
Diazoxide—Purpura—Epirubicin—urinary bladder cancer	0.00133	0.00247	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00133	0.00246	CcSEcCtD
Diazoxide—Oedema—Gemcitabine—urinary bladder cancer	0.00132	0.00245	CcSEcCtD
Diazoxide—Oedema—Fluorouracil—urinary bladder cancer	0.0013	0.0024	CcSEcCtD
Diazoxide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00129	0.0024	CcSEcCtD
Diazoxide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00129	0.00239	CcSEcCtD
Diazoxide—Diplopia—Epirubicin—urinary bladder cancer	0.00128	0.00238	CcSEcCtD
Diazoxide—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00128	0.00238	CcSEcCtD
Diazoxide—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00128	0.00237	CcSEcCtD
Diazoxide—Anxiety—Cisplatin—urinary bladder cancer	0.00128	0.00237	CcSEcCtD
Diazoxide—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00127	0.00236	CcSEcCtD
Diazoxide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00127	0.00235	CcSEcCtD
Diazoxide—Discomfort—Cisplatin—urinary bladder cancer	0.00127	0.00235	CcSEcCtD
Diazoxide—Tachycardia—Fluorouracil—urinary bladder cancer	0.00126	0.00235	CcSEcCtD
Diazoxide—Anorexia—Gemcitabine—urinary bladder cancer	0.00126	0.00233	CcSEcCtD
Diazoxide—Malaise—Etoposide—urinary bladder cancer	0.00124	0.00231	CcSEcCtD
Diazoxide—Abdominal pain—Thiotepa—urinary bladder cancer	0.00124	0.0023	CcSEcCtD
Diazoxide—Body temperature increased—Thiotepa—urinary bladder cancer	0.00124	0.0023	CcSEcCtD
Diazoxide—Anorexia—Fluorouracil—urinary bladder cancer	0.00124	0.00229	CcSEcCtD
Diazoxide—Leukopenia—Etoposide—urinary bladder cancer	0.00123	0.00229	CcSEcCtD
Diazoxide—Purpura—Doxorubicin—urinary bladder cancer	0.00123	0.00229	CcSEcCtD
Diazoxide—Hypotension—Gemcitabine—urinary bladder cancer	0.00123	0.00229	CcSEcCtD
Diazoxide—Oedema—Cisplatin—urinary bladder cancer	0.00123	0.00228	CcSEcCtD
Diazoxide—Hypotension—Fluorouracil—urinary bladder cancer	0.00121	0.00225	CcSEcCtD
Diazoxide—ATP1A1—Ion channel transport—TRPV1—urinary bladder cancer	0.0012	0.02	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.0012	0.00223	CcSEcCtD
Diazoxide—Tachycardia—Cisplatin—urinary bladder cancer	0.0012	0.00222	CcSEcCtD
Diazoxide—Insomnia—Gemcitabine—urinary bladder cancer	0.00119	0.00221	CcSEcCtD
Diazoxide—Hypertension—Etoposide—urinary bladder cancer	0.00119	0.00221	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—urinary bladder cancer	0.00119	0.0022	CcSEcCtD
Diazoxide—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00119	0.0022	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—MPO—urinary bladder cancer	0.00118	0.0197	CbGpPWpGaD
Diazoxide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00118	0.0022	CcSEcCtD
Diazoxide—Chest pain—Etoposide—urinary bladder cancer	0.00117	0.00218	CcSEcCtD
Diazoxide—Eosinophilia—Methotrexate—urinary bladder cancer	0.00117	0.00218	CcSEcCtD
Diazoxide—Insomnia—Fluorouracil—urinary bladder cancer	0.00117	0.00217	CcSEcCtD
Diazoxide—Anorexia—Cisplatin—urinary bladder cancer	0.00117	0.00217	CcSEcCtD
Diazoxide—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00117	0.00217	CcSEcCtD
Diazoxide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00116	0.00216	CcSEcCtD
Diazoxide—Pancreatitis—Methotrexate—urinary bladder cancer	0.00116	0.00216	CcSEcCtD
Diazoxide—Discomfort—Etoposide—urinary bladder cancer	0.00116	0.00215	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00116	0.00214	CcSEcCtD
Diazoxide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00115	0.00214	CcSEcCtD
Diazoxide—Hypotension—Cisplatin—urinary bladder cancer	0.00115	0.00213	CcSEcCtD
Diazoxide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00115	0.00213	CcSEcCtD
Diazoxide—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00114	0.00211	CcSEcCtD
Diazoxide—Pain—Gemcitabine—urinary bladder cancer	0.00113	0.00209	CcSEcCtD
Diazoxide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00113	0.00209	CcSEcCtD
Diazoxide—Asthenia—Thiotepa—urinary bladder cancer	0.00112	0.00209	CcSEcCtD
Diazoxide—Pruritus—Thiotepa—urinary bladder cancer	0.00111	0.00206	CcSEcCtD
Diazoxide—Pain—Fluorouracil—urinary bladder cancer	0.00111	0.00206	CcSEcCtD
Diazoxide—Paraesthesia—Cisplatin—urinary bladder cancer	0.0011	0.00205	CcSEcCtD
Diazoxide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.0011	0.00204	CcSEcCtD
Diazoxide—Tachycardia—Etoposide—urinary bladder cancer	0.0011	0.00204	CcSEcCtD
Diazoxide—Eosinophilia—Epirubicin—urinary bladder cancer	0.0011	0.00204	CcSEcCtD
Diazoxide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00109	0.00202	CcSEcCtD
Diazoxide—Pancreatitis—Epirubicin—urinary bladder cancer	0.00109	0.00202	CcSEcCtD
Diazoxide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00109	0.00202	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00108	0.00201	CcSEcCtD
Diazoxide—Anorexia—Etoposide—urinary bladder cancer	0.00107	0.00199	CcSEcCtD
Diazoxide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00107	0.00199	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00107	0.00198	CcSEcCtD
Diazoxide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00107	0.00198	CcSEcCtD
Diazoxide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00107	0.00198	CcSEcCtD
Diazoxide—Hypotension—Etoposide—urinary bladder cancer	0.00105	0.00195	CcSEcCtD
Diazoxide—Pain—Cisplatin—urinary bladder cancer	0.00105	0.00195	CcSEcCtD
Diazoxide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00104	0.00193	CcSEcCtD
Diazoxide—Dizziness—Thiotepa—urinary bladder cancer	0.00104	0.00192	CcSEcCtD
Diazoxide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00102	0.0019	CcSEcCtD
Diazoxide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00102	0.00189	CcSEcCtD
Diazoxide—Sweating—Methotrexate—urinary bladder cancer	0.00101	0.00188	CcSEcCtD
Diazoxide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00101	0.00188	CcSEcCtD
Diazoxide—Paraesthesia—Etoposide—urinary bladder cancer	0.00101	0.00188	CcSEcCtD
Diazoxide—Weight increased—Epirubicin—urinary bladder cancer	0.00101	0.00187	CcSEcCtD
Diazoxide—Haematuria—Methotrexate—urinary bladder cancer	0.00101	0.00187	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00101	0.00187	CcSEcCtD
Diazoxide—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.001	0.00186	CcSEcCtD
Diazoxide—Vomiting—Thiotepa—urinary bladder cancer	0.000996	0.00185	CcSEcCtD
Diazoxide—Rash—Thiotepa—urinary bladder cancer	0.000988	0.00183	CcSEcCtD
Diazoxide—Dermatitis—Thiotepa—urinary bladder cancer	0.000987	0.00183	CcSEcCtD
Diazoxide—Headache—Thiotepa—urinary bladder cancer	0.000982	0.00182	CcSEcCtD
Diazoxide—Decreased appetite—Etoposide—urinary bladder cancer	0.000979	0.00182	CcSEcCtD
Diazoxide—Body temperature increased—Cisplatin—urinary bladder cancer	0.000971	0.0018	CcSEcCtD
Diazoxide—Pain—Etoposide—urinary bladder cancer	0.000963	0.00179	CcSEcCtD
Diazoxide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000955	0.00177	CcSEcCtD
Diazoxide—Haemoglobin—Methotrexate—urinary bladder cancer	0.000954	0.00177	CcSEcCtD
Diazoxide—Haemorrhage—Methotrexate—urinary bladder cancer	0.000949	0.00176	CcSEcCtD
Diazoxide—Sweating—Epirubicin—urinary bladder cancer	0.000948	0.00176	CcSEcCtD
Diazoxide—Asthenia—Gemcitabine—urinary bladder cancer	0.000946	0.00175	CcSEcCtD
Diazoxide—Haematuria—Epirubicin—urinary bladder cancer	0.000943	0.00175	CcSEcCtD
Diazoxide—Weight increased—Doxorubicin—urinary bladder cancer	0.000934	0.00173	CcSEcCtD
Diazoxide—Pruritus—Gemcitabine—urinary bladder cancer	0.000933	0.00173	CcSEcCtD
Diazoxide—Nausea—Thiotepa—urinary bladder cancer	0.000931	0.00173	CcSEcCtD
Diazoxide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000928	0.00172	CcSEcCtD
Diazoxide—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000926	0.00172	CcSEcCtD
Diazoxide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00092	0.00171	CcSEcCtD
Diazoxide—Pruritus—Fluorouracil—urinary bladder cancer	0.000917	0.0017	CcSEcCtD
Diazoxide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000905	0.00168	CcSEcCtD
Diazoxide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000902	0.00167	CcSEcCtD
Diazoxide—Haemoglobin—Epirubicin—urinary bladder cancer	0.000893	0.00166	CcSEcCtD
Diazoxide—Abdominal pain—Etoposide—urinary bladder cancer	0.00089	0.00165	CcSEcCtD
Diazoxide—Body temperature increased—Etoposide—urinary bladder cancer	0.00089	0.00165	CcSEcCtD
Diazoxide—Haemorrhage—Epirubicin—urinary bladder cancer	0.000888	0.00165	CcSEcCtD
Diazoxide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000887	0.00165	CcSEcCtD
Diazoxide—Asthenia—Cisplatin—urinary bladder cancer	0.000882	0.00164	CcSEcCtD
Diazoxide—Sweating—Doxorubicin—urinary bladder cancer	0.000878	0.00163	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—urinary bladder cancer	0.000873	0.00162	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDH1—urinary bladder cancer	0.000859	0.0143	CbGpPWpGaD
Diazoxide—Dizziness—Fluorouracil—urinary bladder cancer	0.000857	0.00159	CcSEcCtD
Diazoxide—GLUL—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.000844	0.014	CbGpPWpGaD
Diazoxide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000841	0.00156	CcSEcCtD
Diazoxide—Vomiting—Gemcitabine—urinary bladder cancer	0.000838	0.00156	CcSEcCtD
Diazoxide—Rash—Gemcitabine—urinary bladder cancer	0.000831	0.00154	CcSEcCtD
Diazoxide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00083	0.00154	CcSEcCtD
Diazoxide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000829	0.00154	CcSEcCtD
Diazoxide—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000826	0.00153	CcSEcCtD
Diazoxide—Headache—Gemcitabine—urinary bladder cancer	0.000826	0.00153	CcSEcCtD
Diazoxide—Flushing—Epirubicin—urinary bladder cancer	0.000824	0.00153	CcSEcCtD
Diazoxide—Vomiting—Fluorouracil—urinary bladder cancer	0.000824	0.00153	CcSEcCtD
Diazoxide—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000822	0.00152	CcSEcCtD
Diazoxide—Rash—Fluorouracil—urinary bladder cancer	0.000817	0.00152	CcSEcCtD
Diazoxide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000816	0.00151	CcSEcCtD
Diazoxide—Headache—Fluorouracil—urinary bladder cancer	0.000812	0.00151	CcSEcCtD
Diazoxide—Asthenia—Etoposide—urinary bladder cancer	0.000808	0.0015	CcSEcCtD
Diazoxide—Pruritus—Etoposide—urinary bladder cancer	0.000796	0.00148	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CREBBP—urinary bladder cancer	0.000789	0.0131	CbGpPWpGaD
Diazoxide—Nausea—Gemcitabine—urinary bladder cancer	0.000783	0.00145	CcSEcCtD
Diazoxide—Vomiting—Cisplatin—urinary bladder cancer	0.000781	0.00145	CcSEcCtD
Diazoxide—Vision blurred—Methotrexate—urinary bladder cancer	0.000779	0.00144	CcSEcCtD
Diazoxide—Rash—Cisplatin—urinary bladder cancer	0.000775	0.00144	CcSEcCtD
Diazoxide—Dermatitis—Cisplatin—urinary bladder cancer	0.000774	0.00144	CcSEcCtD
Diazoxide—Diarrhoea—Etoposide—urinary bladder cancer	0.00077	0.00143	CcSEcCtD
Diazoxide—Nausea—Fluorouracil—urinary bladder cancer	0.00077	0.00143	CcSEcCtD
Diazoxide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000767	0.00142	CcSEcCtD
Diazoxide—Flushing—Doxorubicin—urinary bladder cancer	0.000763	0.00141	CcSEcCtD
Diazoxide—Malaise—Methotrexate—urinary bladder cancer	0.000745	0.00138	CcSEcCtD
Diazoxide—Dizziness—Etoposide—urinary bladder cancer	0.000744	0.00138	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000741	0.0123	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000741	0.0123	CbGpPWpGaD
Diazoxide—Leukopenia—Methotrexate—urinary bladder cancer	0.000739	0.00137	CcSEcCtD
Diazoxide—Nausea—Cisplatin—urinary bladder cancer	0.00073	0.00135	CcSEcCtD
Diazoxide—Vision blurred—Epirubicin—urinary bladder cancer	0.000729	0.00135	CcSEcCtD
Diazoxide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000717	0.00133	CcSEcCtD
Diazoxide—Vomiting—Etoposide—urinary bladder cancer	0.000716	0.00133	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00071	0.0118	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00071	0.0118	CbGpPWpGaD
Diazoxide—Rash—Etoposide—urinary bladder cancer	0.00071	0.00132	CcSEcCtD
Diazoxide—Dermatitis—Etoposide—urinary bladder cancer	0.000709	0.00132	CcSEcCtD
Diazoxide—Headache—Etoposide—urinary bladder cancer	0.000705	0.00131	CcSEcCtD
Diazoxide—Chest pain—Methotrexate—urinary bladder cancer	0.000703	0.0013	CcSEcCtD
Diazoxide—Malaise—Epirubicin—urinary bladder cancer	0.000697	0.00129	CcSEcCtD
Diazoxide—Discomfort—Methotrexate—urinary bladder cancer	0.000695	0.00129	CcSEcCtD
Diazoxide—Leukopenia—Epirubicin—urinary bladder cancer	0.000692	0.00128	CcSEcCtD
Diazoxide—Palpitations—Epirubicin—urinary bladder cancer	0.000683	0.00127	CcSEcCtD
Diazoxide—KCNJ11—Type II diabetes mellitus—TNF—urinary bladder cancer	0.000679	0.0113	CbGpPWpGaD
Diazoxide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000674	0.00125	CcSEcCtD
Diazoxide—Nausea—Etoposide—urinary bladder cancer	0.000669	0.00124	CcSEcCtD
Diazoxide—Hypertension—Epirubicin—urinary bladder cancer	0.000667	0.00124	CcSEcCtD
Diazoxide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000664	0.00123	CcSEcCtD
Diazoxide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00066	0.00122	CcSEcCtD
Diazoxide—Chest pain—Epirubicin—urinary bladder cancer	0.000658	0.00122	CcSEcCtD
Diazoxide—Anxiety—Epirubicin—urinary bladder cancer	0.000656	0.00122	CcSEcCtD
Diazoxide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000652	0.00121	CcSEcCtD
Diazoxide—Discomfort—Epirubicin—urinary bladder cancer	0.00065	0.00121	CcSEcCtD
Diazoxide—Malaise—Doxorubicin—urinary bladder cancer	0.000645	0.0012	CcSEcCtD
Diazoxide—Anorexia—Methotrexate—urinary bladder cancer	0.000643	0.00119	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—urinary bladder cancer	0.00064	0.00119	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—urinary bladder cancer	0.000632	0.00117	CcSEcCtD
Diazoxide—Oedema—Epirubicin—urinary bladder cancer	0.000631	0.00117	CcSEcCtD
Diazoxide—Hypotension—Methotrexate—urinary bladder cancer	0.00063	0.00117	CcSEcCtD
Diazoxide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000618	0.00115	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—urinary bladder cancer	0.000618	0.00115	CcSEcCtD
Diazoxide—Tachycardia—Epirubicin—urinary bladder cancer	0.000616	0.00114	CcSEcCtD
Diazoxide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00061	0.00113	CcSEcCtD
Diazoxide—Insomnia—Methotrexate—urinary bladder cancer	0.00061	0.00113	CcSEcCtD
Diazoxide—Chest pain—Doxorubicin—urinary bladder cancer	0.000609	0.00113	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—urinary bladder cancer	0.000607	0.00113	CcSEcCtD
Diazoxide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000605	0.00112	CcSEcCtD
Diazoxide—Discomfort—Doxorubicin—urinary bladder cancer	0.000602	0.00112	CcSEcCtD
Diazoxide—Anorexia—Epirubicin—urinary bladder cancer	0.000601	0.00112	CcSEcCtD
Diazoxide—Hypotension—Epirubicin—urinary bladder cancer	0.00059	0.00109	CcSEcCtD
Diazoxide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000586	0.00109	CcSEcCtD
Diazoxide—Oedema—Doxorubicin—urinary bladder cancer	0.000584	0.00108	CcSEcCtD
Diazoxide—Pain—Methotrexate—urinary bladder cancer	0.000577	0.00107	CcSEcCtD
Diazoxide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000572	0.00106	CcSEcCtD
Diazoxide—Insomnia—Epirubicin—urinary bladder cancer	0.000571	0.00106	CcSEcCtD
Diazoxide—Tachycardia—Doxorubicin—urinary bladder cancer	0.00057	0.00106	CcSEcCtD
Diazoxide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000567	0.00105	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000564	0.00105	CcSEcCtD
Diazoxide—Anorexia—Doxorubicin—urinary bladder cancer	0.000557	0.00103	CcSEcCtD
Diazoxide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000556	0.00103	CcSEcCtD
Diazoxide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000551	0.00102	CcSEcCtD
Diazoxide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000549	0.00102	CcSEcCtD
Diazoxide—Hypotension—Doxorubicin—urinary bladder cancer	0.000546	0.00101	CcSEcCtD
Diazoxide—Pain—Epirubicin—urinary bladder cancer	0.00054	0.001	CcSEcCtD
Diazoxide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000533	0.000989	CcSEcCtD
Diazoxide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000533	0.000989	CcSEcCtD
Diazoxide—Insomnia—Doxorubicin—urinary bladder cancer	0.000528	0.00098	CcSEcCtD
Diazoxide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000524	0.000973	CcSEcCtD
Diazoxide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00052	0.000965	CcSEcCtD
Diazoxide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000516	0.000957	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000514	0.00854	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000514	0.00854	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.00051	0.00848	CbGpPWpGaD
Diazoxide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000508	0.000942	CcSEcCtD
Diazoxide—Pain—Doxorubicin—urinary bladder cancer	0.000499	0.000926	CcSEcCtD
Diazoxide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000499	0.000925	CcSEcCtD
Diazoxide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000499	0.000925	CcSEcCtD
Diazoxide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000497	0.000922	CcSEcCtD
Diazoxide—Asthenia—Methotrexate—urinary bladder cancer	0.000484	0.000898	CcSEcCtD
Diazoxide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000481	0.000893	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000479	0.00796	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000477	0.000886	CcSEcCtD
Diazoxide—Pruritus—Methotrexate—urinary bladder cancer	0.000477	0.000885	CcSEcCtD
Diazoxide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000465	0.000863	CcSEcCtD
Diazoxide—GLUL—Metabolism—GSTZ1—urinary bladder cancer	0.000463	0.0077	CbGpPWpGaD
Diazoxide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000462	0.000856	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000462	0.000856	CcSEcCtD
Diazoxide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000461	0.000856	CcSEcCtD
Diazoxide—Asthenia—Epirubicin—urinary bladder cancer	0.000453	0.00084	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000447	0.00742	CbGpPWpGaD
Diazoxide—Pruritus—Epirubicin—urinary bladder cancer	0.000446	0.000828	CcSEcCtD
Diazoxide—Dizziness—Methotrexate—urinary bladder cancer	0.000446	0.000827	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000446	0.00741	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000441	0.00732	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTO2—urinary bladder cancer	0.000439	0.0073	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NAT1—urinary bladder cancer	0.000439	0.0073	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—TNF—urinary bladder cancer	0.000436	0.00725	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—urinary bladder cancer	0.000433	0.00719	CbGpPWpGaD
Diazoxide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000432	0.000801	CcSEcCtD
Diazoxide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00043	0.000798	CcSEcCtD
Diazoxide—Vomiting—Methotrexate—urinary bladder cancer	0.000429	0.000795	CcSEcCtD
Diazoxide—Rash—Methotrexate—urinary bladder cancer	0.000425	0.000789	CcSEcCtD
Diazoxide—Dermatitis—Methotrexate—urinary bladder cancer	0.000425	0.000788	CcSEcCtD
Diazoxide—Headache—Methotrexate—urinary bladder cancer	0.000422	0.000784	CcSEcCtD
Diazoxide—Asthenia—Doxorubicin—urinary bladder cancer	0.000419	0.000777	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000419	0.00696	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000419	0.00696	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.000418	0.00694	CbGpPWpGaD
Diazoxide—Dizziness—Epirubicin—urinary bladder cancer	0.000417	0.000774	CcSEcCtD
Diazoxide—Pruritus—Doxorubicin—urinary bladder cancer	0.000413	0.000766	CcSEcCtD
Diazoxide—GLUL—Metabolism—UGT2B7—urinary bladder cancer	0.000402	0.00667	CbGpPWpGaD
Diazoxide—Vomiting—Epirubicin—urinary bladder cancer	0.000401	0.000744	CcSEcCtD
Diazoxide—Nausea—Methotrexate—urinary bladder cancer	0.0004	0.000743	CcSEcCtD
Diazoxide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000399	0.000741	CcSEcCtD
Diazoxide—Rash—Epirubicin—urinary bladder cancer	0.000398	0.000738	CcSEcCtD
Diazoxide—Dermatitis—Epirubicin—urinary bladder cancer	0.000397	0.000737	CcSEcCtD
Diazoxide—Headache—Epirubicin—urinary bladder cancer	0.000395	0.000733	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—FAS—urinary bladder cancer	0.000395	0.00657	CbGpPWpGaD
Diazoxide—Dizziness—Doxorubicin—urinary bladder cancer	0.000386	0.000716	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000377	0.00627	CbGpPWpGaD
Diazoxide—Nausea—Epirubicin—urinary bladder cancer	0.000375	0.000695	CcSEcCtD
Diazoxide—Vomiting—Doxorubicin—urinary bladder cancer	0.000371	0.000689	CcSEcCtD
Diazoxide—Rash—Doxorubicin—urinary bladder cancer	0.000368	0.000683	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—urinary bladder cancer	0.000368	0.00611	CbGpPWpGaD
Diazoxide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000368	0.000682	CcSEcCtD
Diazoxide—Headache—Doxorubicin—urinary bladder cancer	0.000366	0.000679	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000365	0.00607	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP4B1—urinary bladder cancer	0.000362	0.00601	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000348	0.00578	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—EP300—urinary bladder cancer	0.000347	0.00577	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—urinary bladder cancer	0.000347	0.000643	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000346	0.00576	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC19A1—urinary bladder cancer	0.000341	0.00567	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PRSS3—urinary bladder cancer	0.000333	0.00553	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000316	0.00525	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000303	0.00503	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.00029	0.00483	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000283	0.0047	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000283	0.0047	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000282	0.00469	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.00028	0.00465	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.000278	0.00463	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000275	0.00457	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NAT1—urinary bladder cancer	0.000275	0.00457	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMP—urinary bladder cancer	0.000266	0.00442	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTO2—urinary bladder cancer	0.000264	0.00439	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NAT1—urinary bladder cancer	0.000264	0.00439	CbGpPWpGaD
Diazoxide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.000252	0.00418	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IFNA2—urinary bladder cancer	0.000248	0.00412	CbGpPWpGaD
Diazoxide—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.000241	0.00401	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NAT2—urinary bladder cancer	0.000241	0.004	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000238	0.00395	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTZ1—urinary bladder cancer	0.000237	0.00393	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTZ1—urinary bladder cancer	0.00023	0.00381	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000227	0.00377	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTO2—urinary bladder cancer	0.000224	0.00373	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NAT1—urinary bladder cancer	0.000224	0.00373	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NAT1—urinary bladder cancer	0.000218	0.00362	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTO2—urinary bladder cancer	0.000218	0.00362	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000217	0.00361	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000217	0.0036	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000214	0.00356	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000209	0.00347	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—RRM2—urinary bladder cancer	0.000208	0.00345	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—EP300—urinary bladder cancer	0.000207	0.00343	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000205	0.00341	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—UGT2B7—urinary bladder cancer	0.000205	0.00341	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.0002	0.00332	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—UGT2B7—urinary bladder cancer	0.000199	0.00331	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000198	0.00328	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ENO2—urinary bladder cancer	0.000192	0.0032	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—HPGDS—urinary bladder cancer	0.000192	0.0032	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000191	0.00317	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTT1—urinary bladder cancer	0.000187	0.0031	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP4B1—urinary bladder cancer	0.000185	0.00307	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP4B1—urinary bladder cancer	0.000179	0.00298	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PLAU—urinary bladder cancer	0.000176	0.00292	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC19A1—urinary bladder cancer	0.000174	0.0029	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PRSS3—urinary bladder cancer	0.00017	0.00283	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC19A1—urinary bladder cancer	0.000169	0.00281	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000167	0.00277	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PRSS3—urinary bladder cancer	0.000165	0.00274	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMP—urinary bladder cancer	0.00016	0.00266	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NQO1—urinary bladder cancer	0.000155	0.00258	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—HRAS—urinary bladder cancer	0.000151	0.00252	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000151	0.00251	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.000148	0.00246	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—CREBBP—urinary bladder cancer	0.000145	0.00241	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NAT2—urinary bladder cancer	0.000145	0.0024	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IGF1—urinary bladder cancer	0.000143	0.00238	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMP—urinary bladder cancer	0.000136	0.00226	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000132	0.0022	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000132	0.0022	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMP—urinary bladder cancer	0.000132	0.00219	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—RHOA—urinary bladder cancer	0.000131	0.00218	CbGpPWpGaD
Diazoxide—CA2—Metabolism—RRM2—urinary bladder cancer	0.00013	0.00216	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTP1—urinary bladder cancer	0.000129	0.00215	CbGpPWpGaD
Diazoxide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000125	0.00207	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NAT2—urinary bladder cancer	0.000123	0.00204	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000121	0.002	CbGpPWpGaD
Diazoxide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000121	0.002	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMS—urinary bladder cancer	0.00012	0.002	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NAT2—urinary bladder cancer	0.000119	0.00198	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NCOR1—urinary bladder cancer	0.000119	0.00197	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTM1—urinary bladder cancer	0.000119	0.00197	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000117	0.00194	CbGpPWpGaD
Diazoxide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.000116	0.00192	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ENO2—urinary bladder cancer	0.000116	0.00192	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GPX1—urinary bladder cancer	0.000114	0.00189	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000112	0.00186	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ERCC2—urinary bladder cancer	0.000112	0.00186	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IL2—urinary bladder cancer	0.00011	0.00183	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—urinary bladder cancer	0.000109	0.00181	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—RRM2—urinary bladder cancer	0.000106	0.00176	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—MTHFR—urinary bladder cancer	0.000105	0.00175	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—RRM2—urinary bladder cancer	0.000103	0.00171	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—EP300—urinary bladder cancer	9.87e-05	0.00164	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—HPGDS—urinary bladder cancer	9.83e-05	0.00163	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ENO2—urinary bladder cancer	9.83e-05	0.00163	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NQO1—urinary bladder cancer	9.72e-05	0.00162	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SRC—urinary bladder cancer	9.6e-05	0.0016	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTT1—urinary bladder cancer	9.53e-05	0.00158	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ENO2—urinary bladder cancer	9.53e-05	0.00158	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—HPGDS—urinary bladder cancer	9.53e-05	0.00158	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NQO1—urinary bladder cancer	9.32e-05	0.00155	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTT1—urinary bladder cancer	9.24e-05	0.00154	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.92e-05	0.00148	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPARG—urinary bladder cancer	8.52e-05	0.00142	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CREBBP—urinary bladder cancer	8.18e-05	0.00136	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTP1—urinary bladder cancer	8.11e-05	0.00135	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—urinary bladder cancer	7.95e-05	0.00132	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NQO1—urinary bladder cancer	7.92e-05	0.00132	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTP1—urinary bladder cancer	7.77e-05	0.00129	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—urinary bladder cancer	7.74e-05	0.00129	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NQO1—urinary bladder cancer	7.68e-05	0.00128	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMS—urinary bladder cancer	7.54e-05	0.00125	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—urinary bladder cancer	7.5e-05	0.00125	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTM1—urinary bladder cancer	7.45e-05	0.00124	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NCOR1—urinary bladder cancer	7.45e-05	0.00124	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMS—urinary bladder cancer	7.22e-05	0.0012	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTM1—urinary bladder cancer	7.14e-05	0.00119	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NCOR1—urinary bladder cancer	7.14e-05	0.00119	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GPX1—urinary bladder cancer	7.13e-05	0.00119	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—urinary bladder cancer	7.06e-05	0.00117	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ERCC2—urinary bladder cancer	7e-05	0.00116	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GPX1—urinary bladder cancer	6.84e-05	0.00114	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—urinary bladder cancer	6.76e-05	0.00112	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ERCC2—urinary bladder cancer	6.71e-05	0.00112	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—urinary bladder cancer	6.7e-05	0.00111	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTP1—urinary bladder cancer	6.61e-05	0.0011	CbGpPWpGaD
Diazoxide—CA2—Metabolism—MTHFR—urinary bladder cancer	6.58e-05	0.00109	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTP1—urinary bladder cancer	6.41e-05	0.00106	CbGpPWpGaD
Diazoxide—CA1—Metabolism—MTHFR—urinary bladder cancer	6.31e-05	0.00105	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMS—urinary bladder cancer	6.14e-05	0.00102	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NCOR1—urinary bladder cancer	6.07e-05	0.00101	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTM1—urinary bladder cancer	6.07e-05	0.00101	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMS—urinary bladder cancer	5.96e-05	0.00099	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NCOR1—urinary bladder cancer	5.89e-05	0.000979	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTM1—urinary bladder cancer	5.89e-05	0.000979	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—urinary bladder cancer	5.84e-05	0.000971	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GPX1—urinary bladder cancer	5.81e-05	0.000966	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ERCC2—urinary bladder cancer	5.71e-05	0.000949	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GPX1—urinary bladder cancer	5.64e-05	0.000937	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—EP300—urinary bladder cancer	5.57e-05	0.000926	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ERCC2—urinary bladder cancer	5.54e-05	0.00092	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—MTHFR—urinary bladder cancer	5.37e-05	0.000892	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPARG—urinary bladder cancer	5.34e-05	0.000887	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—MTHFR—urinary bladder cancer	5.2e-05	0.000865	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CREBBP—urinary bladder cancer	5.13e-05	0.000852	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPARG—urinary bladder cancer	5.12e-05	0.000851	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CREBBP—urinary bladder cancer	4.92e-05	0.000817	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPARG—urinary bladder cancer	4.35e-05	0.000723	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPARG—urinary bladder cancer	4.22e-05	0.000701	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—urinary bladder cancer	4.2e-05	0.000698	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CREBBP—urinary bladder cancer	4.18e-05	0.000695	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CREBBP—urinary bladder cancer	4.05e-05	0.000674	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—urinary bladder cancer	4.03e-05	0.000669	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—urinary bladder cancer	3.66e-05	0.000609	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—urinary bladder cancer	3.51e-05	0.000583	CbGpPWpGaD
Diazoxide—CA2—Metabolism—EP300—urinary bladder cancer	3.49e-05	0.00058	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—urinary bladder cancer	3.42e-05	0.000569	CbGpPWpGaD
Diazoxide—CA1—Metabolism—EP300—urinary bladder cancer	3.35e-05	0.000556	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—urinary bladder cancer	3.32e-05	0.000552	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—urinary bladder cancer	2.99e-05	0.000496	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—urinary bladder cancer	2.89e-05	0.000481	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—EP300—urinary bladder cancer	2.85e-05	0.000473	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—EP300—urinary bladder cancer	2.76e-05	0.000459	CbGpPWpGaD
